BioLineRx (BLRX) EPS (Weighted Average and Diluted) (2021 - 2025)
BioLineRx (BLRX) recorded quarterly EPS (Weighted Average and Diluted) of -$0.0 in Q4 2025, down 2895.37% quarter-over-quarter from $0.0 in Q4 2024, and down 2895.37% on a YoY basis from $0.0 in Q4 2024.
BioLineRx (BLRX) EPS (Weighted Average and Diluted) (2021 - 2025) Analysis & Trends
BioLineRx's EPS (Weighted Average and Diluted) history runs 5 years deep, the most recent figure standing at -$0.0 for Q4 2025.
- In Q4 2025, EPS (Weighted Average and Diluted) fell 2895.37% year-over-year to -$0.0; the TTM figure through Dec 2025 stood at -$0.0 (down 2895.37% YoY), while the FY2025 annual figure was -$0.0, up 69.4% from the prior year.
- EPS (Weighted Average and Diluted) was -$0.0 for Q4 2025 at BioLineRx, down from $0.0 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.02 in Q2 2023 to a low of -$0.02 in Q4 2023.
- Historically, EPS (Weighted Average and Diluted) has averaged $0.0 across 5 years, with a median of $0.01 in 2021.
- The sharpest annual moves came in 2024 and 2025: EPS (Weighted Average and Diluted) soared 100.22% in 2024, then sank 2895.37% in 2025.
- A 5-year view of EPS (Weighted Average and Diluted) shows it stood at $0.01 in 2021, then changed by 0.0% to $0.01 in 2022, then tumbled by 302.39% to -$0.02 in 2023, then jumped by 100.22% to $0.0 in 2024, then sank by 2895.37% to -$0.0 in 2025.
- The last three EPS (Weighted Average and Diluted) figures came in at -$0.0 (Q4 2025), $0.0 (Q4 2024), and -$0.02 (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 0.68 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.06 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3,086.42 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 4.02 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.61 |
| 10 | BioLineRx | 227.63 Mn | 211.90 Mn | 154,000.00 | 0.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.00 |
| Dec 31, 2024 | 0.00 |
| Dec 31, 2023 | -0.02 |
| Jun 30, 2023 | 0.02 |
| Jun 30, 2022 | 0.01 |
| Jun 30, 2021 | 0.01 |